Join to view full profile
12902 Usf Magnolia DrTampa, FL 33612
Phone+1 813-979-7208
Fax+1 813-979-3071
Dr. Field is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Teresa Field is a hematologist based in Tampa, FL, with a medical degree from the University of Wisconsin School of Medicine & Public Health. She completed her residency in Internal Medicine and a fellowship in Hematology and Medical Oncology at the University of Wisconsin Hospitals and Clinics. Her expertise includes nutrition, hematologic oncology, myelofibrosis, hematopoietic stem cell transplantation, and multiple myeloma. She has contributed to numerous research publications, particularly in the field of hematopoietic cell transplantation, with several studies cited frequently by other professionals. Dr. Field has also been involved in clinical trials related to graft-versus-host disease and multiple myeloma. She received several CMS Meaningful Use Stage 1 Certifications in 2014.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1996 - 1998- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1993 - 1996
University of Wisconsin School of Medicine & Public HealthClass of 1993
Certifications & Licensure
FL State Medical License 1998 - 2027
WI State Medical License 1997 - 2009
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014
Clinical Trials
- Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
- Bone Marrow Transplant in Treating Patients With Hematologic Cancers
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
Publications & Presentations
PubMed
- 20 citationsCoping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology.Anna Barata, Brian D. Gonzalez, Steven K. Sutton, Brent J. Small, Paul B. Jacobsen
Journal of Health Psychology. 2018-07-01 - 7 citationsPhase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.Lia Perez, Hugo Fernandez, Pedro Horna, Marcie L. Riches, Frederick L. Locke
Bone Marrow Transplantation. 2018-04-18 - 7 citationsHypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirm...Hemant S. Murthy, Kyle Sheets, Ambuj Kumar, Taiga Nishihori, Alain Mina
Biology of Blood and Marrow Transplantation. 2018-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
